RecruitingNot ApplicableNCT07649876

Virtual Reality to Reduce Anxiety, Agitation and Delirium in Critically Ill Patients


Sponsor

Milton S. Hershey Medical Center

Enrollment

30 participants

Start Date

Jun 2, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

This is a pilot feasibility study examining the use of immersive virtual reality (VR) in adult intensive care unit (ICU) patients. The study evaluates whether brief, non-interactive VR sessions delivered using a commercially available standalone head-mounted display with calming, nature-based content can be delivered safely and effectively within routine SICU workflow. Exploratory objectives assess whether VR sessions are associated with changes in anxiety, agitation, delirium, pain, and sedative medication requirements. This research is not intended to evaluate the safety or effectiveness of the headset and/or the specific VR software used for the research


Eligibility

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Virtual reality (VR) therapy for people with feasibility, tolerance and safety of vr delivery in an adult icu. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALVirtual reality (VR) therapy

VR sessions will use a commercially available headset with non-interactive, immersive content displaying calming nature-based content (e.g., ocean/beach scenes, forests, mountains) delivered through a commercially available VR application


Locations(1)

Penn State Milton S. Hershey Medical Center

Hershey, Pennsylvania, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07649876


Related Trials